The BSE Sensex surged by 544 points, or 0.71%, reaching 76,809, while the Nifty 50 on the NSE climbed 135.25 points, or 0.57%, to close at 23,989.
The broader market also showed strength, with both mid-cap and small-cap indices rising alongside the benchmark, gaining 0.41% and 0.42%, respectively.
Impact On The Stock Market
Sectoral performance highlights:
- Outperformers: Nifty FMCG, Nifty Private Bank, Nifty Chemical
- Underperformers: Nifty IT, Nifty Consumer Durable, Nifty Pharma
| Sector/Index | Performance |
| IT & BPM sector | 1.78% |
| Healthcare sector | -0.36% |
| Oil & Gas sector | 1.02% |
| Real estate sector | 2.26% |
| PSU Bank in India | -0.21% |
Top gainers today
| Company | Share Price (in ₹) | Change % |
| HCL Tech | 1,159.00 | 39.70 |
| TATA Cons. Prod | 1,130.90 | 30.50 |
| NTPC | 355.55 | 7.45 |
| Bajaj Finserv | 1,787.30 | 2.12 |
| HUL | 2,199.90 | 2.3 |
Top losers today
| Company | Share Price (in ₹) | Change % |
| Hindalco | 982.40 | -3.11 |
| JSW Steel | 1,274.30 | -1.71 |
| HDFC Life | 574.40 | -1.17 |
| Apollo Hospital | 8,390.50 | -0.92 |
| Eicher Motors | 7,560.50 | -0.84 |
Market aftermath: Impact on stocks
Pharma stocks slide on prescription-only rules
Cipla fell 0.65%, Sun Pharma down 0.25%, Dr Reddy’s Laboratories dropped 0.36%, and Glenmark declined 0.56% after the government classified all syrup-based medicines as prescription-only. This regulatory change removed OTC status for cough syrups, requiring valid prescriptions, impacting the Nifty Pharma index, which fell 0.47% .
Reliance Industries gains on Morgan Stanley outlook
Reliance Industries rose 2.4% to Rs 1,292.75 after Morgan Stanley maintained an “Overweight” rating with a target price of Rs 1,803, reflecting a potential upside of 40%. The brokerage cited structural support from oil-to-chemicals earnings, solar and energy storage manufacturing, and new AI monetisation opportunities .
SpaceX shares rally on Nasdaq gains
Shares of SpaceX jumped over 8% in pre-market trading after a 19.6% gain in the previous session, marking a 43% surge in its first two days on the Nasdaq. The IPO’s over-allotment option increased the gross raise to $86.2 billion, reinforcing Elon Musk’s trillionaire valuation and the company’s global tech prominence .
Crude oil trends
Crude oil futures declined despite geopolitical optimism:
- August Brent: $82.92 (-0.30%)
- July WTI: $80.65 (-0.12%)
- June MCX crude: ₹7,633 (+0.20%)
- July MCX crude: ₹7,540 (+0.24%)
The market awaited clarity on the US-Iran peace deal. US President Donald Trump confirmed the Strait of Hormuz would reopen, while Iran committed to forgoing nuclear weapons, easing supply concerns. Precious metal and energy-sensitive sectors benefited from improved market sentiment .
Conclusion
Indian markets remain bullish with Nifty approaching the critical 24,000 mark and Bank Nifty testing 57,800. PSU banks, FMCG, and consumer durables supported gains, while IT and pharma lagged due to regulatory and sector-specific concerns. Reliance Industries and SpaceX captured investor attention with strong growth outlooks, while crude oil stabilization and geopolitical optimism sustained risk appetite. Technical indicators suggest consolidation near current levels, with potential upside if Nifty breaches 24,000 and Bank Nifty surpasses 57,800.
